Markets may begin flat following mixed global cues Markets may begin flat following mixed global cues Karan Dsij / Tuesday, June 25, 2019 / Article rating: 5.0 The outlook for the day is a flat start and indices could remain subdued initially on the back of mixed cues from the global markets. At the time of writing, SGX Nifty was up by 12 points at 11,728 level.
NTPC and Power Grid sign MoU, NTPC gains NTPC and Power Grid sign MoU, NTPC gains Shohini Nath / Monday, June 24, 2019 / Article rating: 2.5 NTPC has signed a memorandum of understanding (MoU) with Power Grid Corporation of India.
Emami falls by nearly 7 per cent after block deals Emami falls by nearly 7 per cent after block deals Geyatee Deshpande / Monday, June 24, 2019 / Article rating: 4.5 Share of Emami Limited fell by nearly 7 per cent following block deals in the company's shares. The block deals consisted of promoters selling around 8.3 per cent of their equity stakes.
Intellect Design: Bank of Mongolia deploys Quantum Solution Intellect Design: Bank of Mongolia deploys Quantum Solution Nidhi Jani / Monday, June 24, 2019 / Article rating: 3.8 The solution is expected to give acceleration to the Bank of Mongolia’s digital transformation initiative under the Payment System Modernization project funded by the Asian Development Bank (ADB).
Overnight Digest: Stocks to look out for June 25 Overnight Digest: Stocks to look out for June 25 Geyatee Deshpande / Monday, June 24, 2019 / Article rating: 2.3 The stock to look out on June 25 includes Infosys, Dr. Reddy's Laboratories, NTPC, Future Enterprises and Gujarat Gas.
RITES announces 1:4 bonus shares RITES announces 1:4 bonus shares Gayathri Udyawar / Monday, June 24, 2019 / Article rating: 2.7 The state-owned consultancy company RITES has declared bonus shares in the ratio of 1:4 on Monday, the record date will be announced later.
Alembic Pharma gets USFDA approval for ANDA Alembic Pharma gets USFDA approval for ANDA Pratik Shastri / Monday, June 24, 2019 / Article rating: 5.0 Gujarat-based pharmaceutical company Alembic Pharma announced that it got USFDA approval for ANDA Bromfenac solution, on Monday.
Personal finance myths that may derail your retirement Personal finance myths that may derail your retirement Henil Shah / Monday, June 24, 2019 / Article rating: 5.0 Retirement is a phase wherein you have very low responsibility hence you can enjoy your time without much stress. However, some personal finance myths can derail your retirement. What are they? Let’s find out.
Omkar Speciality Chemicals forays into CRAMS business Omkar Speciality Chemicals forays into CRAMS business Nidhi Jani / Monday, June 24, 2019 / Article rating: 5.0 Omkar Speciality Chemicals has planned to foray into Contract Research and Manufacturing Services (CRAMS) business to move up the value chain in the pharma industry with the help of its strong operational efficiencies backed by robust R&D focused initiatives and multi-product delivery capabilities.
L&T wins mega order in Bihar, stock gains L&T wins mega order in Bihar, stock gains Shohini Nath / Monday, June 24, 2019 / Article rating: 2.5 Larsen & Toubro’s (L&T) Power business has bagged a mega EPC order from SJVN Thermal. The company's shares gained around 1.3 per cent intraday.